Novo hemophila drug approved
The FDA approved Novo Nordisk's Hemophilia A drug Novoeight. The Danish drug maker said in a statement Wednesday that it expects to have the drug on the US market during 2015's second quarter.
The treatment is for a type of hemophilia that typically affects men, and is the result of a missing or malfunctioning factor VIII protein.
The drug was among an elite list of medications approved during the government's 16-day shutdown.